Vivir con un riesgo de cáncer hereditario puede ser extremadamente estresante para todos los pacientes de cáncer. En este episodio, la Dra. Karen Hurley comparte sus ideas sobre cómo gestionar y afrontar la ansiedad que rodea al riesgo y la incertidumbre.
Karen Hurley, PhD, joined the Cleveland Clinic in 2016, bringing with her almost 20 years of experience as a licensed clinical psychologist specializing in hereditary cancer risk and psycho-oncology. She received her undergraduate degree from Bryn Mawr College in 1983 and completed her PhD in clinical psychology at Temple University in 1998. After finishing a postdoctoral fellowship in cancer prevention and control at the Mount Sinai School of Medicine in New York City, she spent eight years on faculty at Memorial Sloan-Kettering Cancer Center, conducting research funded by the National Cancer Institute. She has provided psychotherapy and consultation to hundreds of individuals, couples, and families across the spectrum of cancer from risk to survivorship, and frequently gives lectures to patient and professional audiences, nationally and internationally. She is a member of several national advisory boards, including FORCE, Bright Pink, Sharsheret, and the Cancer Support Community. In 2014 she received a Spirit of Empowerment-Individual Commitment award at the 8th Annual FORCE conference, in recognition of her work on behalf of the hereditary cancer community.
Recursos adicionales
Una segunda ración de estrés: Cómo afrontar el cáncer hereditario durante la pandemia de COVID-19 & Cómo afrontar una ración extra deestrés
Compartir información sobre riesgos con los niños
Beyond the Clinic: Living Well With Melanoma is a twelve-series podcast hosted by Raymond Liu, MD, Director of Cancer Survivorship for Kaiser Permanente San Francisco. For more information on our program, Beyond the Clinic: Living Well with Melanoma, and to find out about upcoming topics and guests, click here.
Entradas recientes
Jun. 06, 2023
Why Peer Support is Important for People Coping With Melanoma
May. 30, 2023
Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
May. 17, 2023
Turning Tragedy into Something Positive to Help Others
May. 09, 2023
A Beginner’s Guide to the End: Practical Guide To Living Life and Facing Death
May. 05, 2023